Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esflurbiprofen Topical System in Acute Contusions
2024-513064-26-00Phase 3Completed
- Sponsor
- Teikoku Seiyaku Co., Ltd.
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of esflurbiprofen in soft tissue contusion and bruise, sponsored by Teikoku Seiyaku Co., Ltd. Primary endpoint: Adverse events (AEs). Started Feb 2025; status: completed.
02
Drugs
esflurbiprofen
03
Conditions
soft tissue contusionbruise
Beyond the preview
Go deeper on 2024-513064-26-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513064-26-00.